Leading Nebraska, Episode 11: UNMC's Andre Kalil, "Testing a Treatment for COVID-19"
University of Nebraska
00:08:05
LinkAbout this episode
A UNMC doctor, Andre Kalil, is using their specialized biocontainment facility in Omaha to lead the way in experimental testing for COVID-19. A drug treatment for coronavirus, remdesivir, was first tested at the University of Nebraska Medical Center in Omaha. While studies are ongoing, the U.S. Food and Drug Administration recently approved remdesivir for treatment of COVID-19.
In this episode of Leading Nebraska, we take a look at the efforts to test remdesivir—and what inspires Andre Kalil to keep searching for effective treatments to COVID-19.
For more stories or to access a transcript of this podcast, visit https://nebraska.edu/nuforne.
This show is based on a story written by Jackie Ostrowicki. It was written and produced by Mary Jane Bruce, co-produced and edited by David Fitzgibbon, and promoted and marketed by Ryan Rothman.
In this episode of Leading Nebraska, we take a look at the efforts to test remdesivir—and what inspires Andre Kalil to keep searching for effective treatments to COVID-19.
For more stories or to access a transcript of this podcast, visit https://nebraska.edu/nuforne.
This show is based on a story written by Jackie Ostrowicki. It was written and produced by Mary Jane Bruce, co-produced and edited by David Fitzgibbon, and promoted and marketed by Ryan Rothman.